Current and historical daily PE Ratio for Jubilant Pharmova Ltd (
) from 1995 to Jun 19 2024. The price to earnings ratio is calculated by taking the current stock price and dividing it by the most recent trailing twelve-month earnings per share (EPS) number. The data is updated every 20 minutes during market hours. The PE ratio can be viewed as the number of years it takes for the company to earn back the price you pay for the stock. Therefore, lower-P/E stocks are more attractive than higher P/E stocks so long as the PE ratio is positive. Also for stocks with the same PE ratio, the one with faster growth business is more attractive. Jubilant Pharmova stock (BOM:530019) PE ratio as of Jun 19 2024 is 151.3.
More Details
Jubilant Pharmova Ltd (BOM:530019) PE Ratio (TTM) Chart
Jubilant Pharmova Ltd (BOM:530019) PE Ratio (TTM) Historical Data
View and export this data going back to 1995. Start your Free Trial
Total 1260
- 1
- 2
- 3
- 4
- 5
- 6
- 14
Jubilant Pharmova PE Ratio (TTM) Historical Data | |||
---|---|---|---|
Date | PE Ratio (TTM) Data | Date | PE Ratio (TTM) Data |
2024-06-19 | 151.3 | 2024-04-09 | 134.5 |
2024-06-18 | 151.3 | 2024-04-08 | 134.7 |
2024-06-14 | 155.6 | 2024-04-05 | 132.8 |
2024-06-13 | 154.1 | 2024-04-04 | 131.5 |
2024-06-12 | 151.9 | 2024-04-03 | 119.2 |
2024-06-11 | 152.6 | 2024-04-02 | 121.9 |
2024-06-10 | 153.3 | 2024-04-01 | 118.3 |
2024-06-07 | 156.3 | 2024-03-28 | 117.2 |
2024-06-06 | 148.6 | 2024-03-27 | 239.2 |
2024-06-05 | 142.2 | 2024-03-26 | 237.2 |
2024-06-04 | 131.9 | 2024-03-22 | 236.9 |
2024-06-03 | 138.3 | 2024-03-21 | 238.5 |
2024-05-31 | 141.3 | 2024-03-20 | 237.9 |
2024-05-29 | 145.5 | 2024-03-19 | 236.8 |
2024-05-28 | 145.1 | 2024-03-18 | 238.6 |
2024-05-27 | 142.3 | 2024-03-14 | 235.9 |
2024-05-24 | 145.6 | 2024-03-13 | 228.7 |
2024-05-23 | 147.9 | 2024-03-12 | 238.3 |
2024-05-22 | 146.4 | 2024-03-11 | 233.7 |
2024-05-21 | 144.8 | 2024-03-07 | 246.9 |
2024-05-17 | 148.4 | 2024-03-06 | 247.8 |
2024-05-16 | 148.4 | 2024-03-05 | 246.4 |
2024-05-15 | 147.6 | 2024-03-04 | 237.9 |
2024-05-14 | 141.8 | 2024-03-01 | 239.9 |
2024-05-13 | 141.8 | 2024-02-29 | 237.3 |
2024-05-10 | 143.8 | 2024-02-28 | 232.7 |
2024-05-09 | 140.2 | 2024-02-27 | 237.9 |
2024-05-08 | 143.9 | 2024-02-26 | 240.7 |
2024-05-07 | 144.5 | 2024-02-23 | 239.5 |
2024-05-06 | 139.8 | 2024-02-22 | 245.2 |
2024-05-03 | 141.5 | 2024-02-21 | 244.1 |
2024-05-02 | 139.4 | 2024-02-20 | 251.3 |
2024-04-30 | 138.8 | 2024-02-19 | 253.7 |
2024-04-29 | 141.5 | 2024-02-16 | 259.4 |
2024-04-26 | 140.3 | 2024-02-15 | 255.9 |
2024-04-25 | 139.5 | 2024-02-14 | 244.3 |
2024-04-24 | 140.7 | 2024-02-13 | 243.9 |
2024-04-23 | 141.2 | 2024-02-12 | 245.3 |
2024-04-22 | 140.4 | 2024-02-09 | 234.4 |
2024-04-19 | 137.3 | 2024-02-08 | 238.4 |
2024-04-18 | 144.7 | 2024-02-07 | 239.9 |
2024-04-16 | 138.5 | 2024-02-06 | 243.3 |
2024-04-15 | 134.0 | 2024-02-05 | 242.1 |
2024-04-12 | 131.8 | 2024-02-02 | 248.4 |
2024-04-10 | 134.2 | 2024-02-01 | 240.9 |
Jubilant Pharmova Ltd (BOM:530019) PE Ratio (TTM) Comparison
Company | Market Cap(Mil) | PE Ratio (TTM) |
---|
Business Description
Business Description
Jubilant Pharmova Ltd
ISIN : INE700A01033
Compare
Compare
Traded in other countries / regions
JUBLPHARMA.India IPO Date
1995-05-05Description
Jubilant Pharmova Ltd is an integrated global pharmaceutical company. The company's segment includes Radiopharma; Allergy Immunotherapy; Contract Development and Manufacturing Organisation - Sterile Injectables; Generics; Contract Research, Development and Manufacturing Organisation and Proprietary Novel Drugs. It generates maximum revenue from the Radiopharma segment. Geographically, it derives a majority of its revenue from Americas and Europe.